Congress Asset Management CO Bristol Myers Squibb CO Transaction History

Congress Asset Management CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$59.17 - $69.31 $235,200 - $275,507	-3,975 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$61.91 - $67.42 $6,500 - $7,079	105 Added 2.71%	3,975 $266,000
Q1 2021 May 05, 2021	SELL	$59.34 - $66.74 $104,082 - $117,061	-1,754 Reduced 31.19%	3,870 $244,000
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $33,258 - $37,687	576 Added 11.41%	5,624 $349,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $19,641 - $21,764	-342 Reduced 6.35%	5,048 $304,000
Q2 2020 Jul 23, 2020	BUY	$54.82 - $64.09 $21,928 - $25,636	400 Added 8.02%	5,390 $317,000
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $245,557 - $320,308	4,990 New	4,990 $320,000
Q2 2019 Aug 07, 2019	SELL	$44.62 - $49.34 $218,593 - $241,716	-4,899 Closed	0 $0
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $105,860 - $131,943	-2,095 Reduced 29.95%	4,899 $271,000
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $31,757 - $36,559	-530 Reduced 7.04%	6,994 $442,000
Q4 2017 Jan 30, 2018	SELL	$59.94 - $65.35 $42,137 - $45,941	-703 Reduced 8.55%	7,524 $461,000
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $454,377 - $524,388	8,227	8,227 $524,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Congress Asset Management CO , based on Form 13F filings with the SEC.

Stay updated on Congress Asset Management CO with notifications on news.